Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients

Published:1999-11 Issue:5 Volume:48 Page:694-703
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Neumayer ,Paradis ,Korn ,Jean ,Fritsche ,Budde ,Winkler ,Kliem ,Pichlmayr ,Hauser ,Burkhardt ,Lison ,Barndt ,Appel-Dingemanse

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.1999.00085.x/fullpdf

Reference9 articles.

1. Reversal of ongoing heart, kidney and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.;Chen;Transplantation,1993

2. Rapamycin distribution pharmacokinetics and therapeutic range investigations.;Yatscoff;Ther Drug Monit,1995

3. SDZ RAD, a new rapamycin derivative. Synergism with cyclosporine.;Schuurman;Transplantation,1997

4. SDZ RAD, a new rapamycin derivative. Pharmacological properties in vitro and in vivo.;Schuler;Transplantation,1997

5. Prediction of creatinine clearance from serum creatinine.;Cockcroft;Nephron,1976

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus;Molecular Biology Reports;2023-01-25

2. Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients;Journal of Clinical Pharmacy and Therapeutics;2022-08-07

3. Immunosuppressants;Therapeutic Drug Monitoring Data;2020

4. Role for primary immunosuppression with everolimus after pulmonary transplantation;Transplant Immunology;2018-08

5. Novel everolimus-loaded nanocarriers for topical treatment of murine experimental autoimmune uveoretinitis (EAU);Experimental Eye Research;2018-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3